Thrivent Financial for Lutherans Acquires 709 Shares of The Clorox Company (NYSE:CLX)

Thrivent Financial for Lutherans boosted its holdings in The Clorox Company (NYSE:CLX) by 8.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,855 shares of the company’s stock after acquiring an additional 709 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Clorox were worth $1,208,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in CLX. J. W. Coons Advisors LLC bought a new stake in shares of Clorox in the 4th quarter worth $214,000. Rafferty Asset Management LLC grew its position in Clorox by 4.3% in the 4th quarter. Rafferty Asset Management LLC now owns 9,626 shares of the company’s stock worth $1,373,000 after purchasing an additional 395 shares in the last quarter. CIBC Private Wealth Group LLC increased its stake in Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after buying an additional 66 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of Clorox by 16.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 16,089 shares of the company’s stock worth $2,294,000 after buying an additional 2,296 shares in the last quarter. Finally, Oppenheimer & Co. Inc. boosted its stake in shares of Clorox by 4.2% in the 4th quarter. Oppenheimer & Co. Inc. now owns 15,159 shares of the company’s stock worth $2,162,000 after buying an additional 607 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.51% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent analyst reports. TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, Wells Fargo & Company decreased their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. Six analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $146.13.

Clorox Trading Up 0.1 %

Shares of CLX opened at $161.57 on Friday. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09. The stock has a market cap of $20.07 billion, a PE ratio of 83.72, a P/E/G ratio of 3.31 and a beta of 0.41. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The business’s 50-day moving average price is $154.91 and its 200-day moving average price is $144.43.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. On average, equities analysts forecast that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.02%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.